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The early (after 21 days) and late (after 4 months) effects of
continuous treatment with captopril on left ventricular
performance, weight and volumes were studied in rats with
myocardial infarction. Early effects were examined in rats
subjected to coronary ligation and randomized to either
immediate treatment with captopril (2 g/liter drinking
water) starting 2 h after surgery or no treatment. After 21
days, the treated group showed reductions in mean arterial,
left ventricular systolic and left ventricular end-diastolic
pressures compared with untreated rats. Right and left
ventricular weight and left ventricular volumes were de-
creased and the ejection fraction index was increased by
captopril treatment.
To study the late effects of captopril, a second group of
rats was randomized to immediate captopril treatment
(starting 2 h after surgery), delayed captopril treatment
Early after myocardial infarction, left ventricular enlarge-
ment can occur as a result of infarct expansion, which
increases the surface area of the infarct by outward bulging,
stretching and thinning of the infarcted region (1-3). The
noninfarcted region also undergoes wall thinning and in-
creased regional radius of curvature in the early postinfarc-
tion period (3,4). During this time, the noninfarcted myocar-
dium undergoes hypertrophy (5,6), In the rat model 5 days
after a large myocardial infarction, the left ventricle demon-
strates moderate dilation (7). The dilation is progressive so
that, by 21 days after myocardial infarction, global cardiac
performance is depressed and the left ventricle is enlarged as
a function of infarct size (7-9). This process initially pre-
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(starting 21 days after surgery) or no treatment. When
studied after 4 months of treatment, rats started on capto-
pril treatment 2 h after infarction showed no differences
compared with rats started on treatment 21 days after
infarction. Treatment with captopril for 4 months pro-
duced changes that were similar to those in rats treated for
21 days.
Captopril treatment improved hemodynamic function
after myocardial infarction in rats examined after either 21
days or 4months of treatment. The extent of the benefit was
similar in the two treatment periods. Initiation of captopril
therapy immediately after infarction did not appear to
produce a greater effect than treatment started at 21 days
after infarction in rats studied after the drug had been
administered for 4 months.
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serves stroke volume and decreases left ventricular filling
pressure (10). However, there appears to be a limit to the
adaptive nature of increasing ventricular volume as evi-
denced by studies (l1,l2) that have shown that survival is
inversely correlated with left ventricular volumes after myo-
cardial infarction. Compensatory mechanisms that promote
ventricular dilation may contribute to deterioration of ven-
tricular function.
Long-term administration of captopril attenuates left ven-
tricular dilation after myocardial infarction (13,14). The
possibility exists that starting treatment with a converting
enzyme inhibitor immediately after infarction could result in
greater benefit than that of treatment initiated later during
the healing phase of infarction. Early treatment could reduce
infarct expansion by reducing afterl6ad, in acidition to effects
on the noninfarcted segment. However, the long-term effects
of immediate initiation of treatment with captopril after
myocardial infarction are unknown. The compensatory
mechanisms that maintain stroke volume and systemic flow
produce alterations of loading conditions and increase ven-
tricular wall stress, thereby stimulating myocardial hyper-
trophy. Blocking these compensatory mechanisms early
after infarction could lead to inadequate myocardial hyper-
0735-1097/90/$3.50
968 GAY
CAPTOPRIL AFTER MYOCARDIAL INFARCTION
lACC Vol. 16. No.4
October 1990:%7-77
trophy, which maintains performance of the infarcted ven-
tricle (15).
The current study was designed to evaluate the effects of
captopril on hemodynamics and left ventricular volumes
after myocardial infarction. Its purpose was to I) determine
whether treatment with captopril started at 2 h after myo-
cardial infarction produces an early benefit by 21 days after
infarction; 2) evaluate whether treatment started at 2 h after
infarction offers an advantage compared with treatment
started 21 days after infarction in rats examined after long-
term therapy; and 3) compare the early effects of captopril at
21 days after infarction with those found after 4 months of
treatment.
Methods
Experimental infarction. Myocardial infarction was pro-
duced in male Sprague-Dawley rats (175 to 225 g in weight)
with use of a technique similar to those described previously
(7-9). After induction of anesthesia with methoxyflurane or I
mllkg body weight of a I: I volumetric solution of ketamine
hydrochloride (100 mg/m/) and xylazine (20 mg/mD injected
intramuscularly, a left thoracotomy was performed and a
ligature was placed around the proximal left coronary artery.
The heart was returned to the chest and the thorax closed.
The early effects of captopril treatment were evaluated
with use of the foUowin/? protocol. Rats that survived for 2 h
were randomly assigned to either immediate treatment with
captopril or a control group. The rats in the immediate
treatment group were placed in cages with captopril (2
g/liter) in the drinking water. The control group received
normal tap water. This dose of captopril was previously
shown (13.14) to produce significant hemodynamic effects in
rats with and without myocardial infarction. These rats were
studied 21 days after the surgical procedure to assess the
effects of captopril early, in the period of healing, after
myocardial infarction.
A second group of rats was studied to evaluate the
long-term effects of treatment with captopril for 4 months.
Rats subjected to coronary artery ligation were assigned 2 h
after the surgical procedure to a group that was placed in
cages with captopril (2 g/liter) in the drinking water (imme-
diate treatment) or to a group that received drinking water
without captopril. After 21 days, the group that initially
received no treatment was divided into two subgroups: one
started receiving captopril in the drinking water at this time
(delayed treatment) and one continued with normal drinking
water. Therefore. in this second study, there were three
groups of rats: the immediate treatment group that began
captopril treatment 2 h after infarction, the delayed treat-
ment group that began treatment 21 days after infarction and
the untreated control group. After 4 months of treatment.
rats were studied according to the protocol described later.
Control group. To determine whether treatment with
captopril produced a hemodynamic effect within 48 h of the
onset of treatment after operation, a group of sham-operated
rats was studied. These rats underwent sham thoracotomy
and were then randomly assigned to immediate treatment
with captopril (2 g/Iiter drinking water) or the control group
that received normal tap water. At 44 to 48 h after the sham
operation and after anesthesia with ketamine and xylazine.
aortic pressure was measured by means of the right carotid
artery using polyethylene tubing, 0.58 mm internal diameter,
connected to a solid state pressure transducer (Millar Instru-
ments). Pressures were recorded twice, at least 5 min apart
after a stable baseline was seen. All rats were maintained on
standard rat chow with free access to water. These studies
conform to the Position of the American Heart Association
on Research Animal Use and were approved by the institu-
tional Animal Research Committee.
Hemodynamic studies. The rats were anesthetized with I
mllkg of a I: I volumetric solution of ketamine hydrochloride
(100 mg/m\) and xylazine (20 mg/m\) injected intramuscu-
larly. Atropine (0.2 mg/kg) was administered intravenously.
The right carotid artery was cannulated with a solid state
pressure transducer (PR-249. Millar Instruments) that was
advanced into the aorta for recording of pressures. The right
external jugular and left femoral veins were cannulated with
polyethylene tubing, 0.58 mm internal diameter. The exter-
nal jugular catheter was connected to a solid state pressure
transducer (Millar Instruments). Body temperature was
maintained between 36° and 38°C by lamps. With the rat
breathing spontaneously, systemic arterial and venous pres-
sures were recorded and the mean values determined by
electronic averaging on a physiologic recorder (model RS
3800, Gould Instruments). The aortic catheter was then
advanced into the left ventricle for recording of pressures
and maximal rate of rise of left ventricular pressure (dP/dt).
Heart rate was determined from the systemic pressure
tracing.
A tracheostomy was performed and the rats were venti-
lated. A mid-sternal thoracotomy was performed by heat
cauterization to expose the ascending aorta. After pulling the
arterial catheter to the distal ascending aorta, a precalibrated
electromagnetic flow probe (2.5 mm internal diameter. Cand
C Instruments) was placed on the ascending aorta. Contin-
uous measurement of phasic and mean aortic blood flows
(cardiac output minus coronary blood flow) were obtained.
Phasic and mean pressures and flow were recorded to
provide baseline hemodynamic values. To assess the maxi-
mal flow-generating capacity of the heart. warmed (39°C)
Tyrode solution was infused (40 ml/min per kg for 45 s) into
a femoral vein (9.13).
Ten minutes after the volume infusion when all hemody-
namic variables had returned to baseline levels, the flow
probe was removed and the aortic catheter was advanced
into the left ventricle. A second volume load was performed
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while recording left ventricular pressure. This permitted
determination of the end-diastolic pressure at which maxi-
mal stroke volume occurred. From these data and the
pressure-volume relation, an index of ejection fraction was
determined (9,13).
Left ventricular pressure-volume relation. Pressure-
volume data were recorded by methods described previously
(7,14,16). After completion of the hemodynamic studies
potassium chloride was injected through the femoral venous
catheter to arrest the heart. The heart was rapidly removed
and the right ventricle was incised. The atrioventricular
groove was identified and a ligature passed around the heart
and tied to isolate the left atrium from the left ventricle.
After gentle aspiration of the left ventricular cavity to
remove any residual blood. saline solution (0.68 ml/min) was
infused into the suspended left ventricle and pressures were
simultaneously recorded. When the pressure increased to 30
mm Hg, the infusion was stopped. Two curves were ob-
tained from each left ventricle within 10 min of cardiac
arrest. These data permit conclusions regarding left ventric-
ular volumes. A rightward shift of the pressure-volume
relation indicates increased volume at any given pressure
that demonstrates ventricular dilation.
Infarct size determination. The ventricles were separated
from the atria and the right ventricular free wall was dis-
sected free of the septum. The left ventricle was opened with
an InCISion along the septum from base to apex. Both
ventricles were rinsed, blotted dry and immediately
weighed. Myocardial infarct size was measured as previ-
ously described (17). Incisions were made in the left ventri-
cle so that left ventricular tissue could be pressed flat. The
circumferences of the left ventricle and the region of infarc-
tion were outlined on a clear plastic sheet for both the
endocardial and epicardial surfaces. Infarct size was calcu-
lated and expressed as a percent of left ventricular surface
area based on the weight of the areas marked on the plastic
sheet. An average of endocardial and epicardial surface
areas was reported. Rats with definite evidence of myocar-
dial infarction but with infarct size <25% were excluded
from the analysis. In the rats with a heart reported as
noninfarcted, no gross evidence of infarction was visible.
Calculations. Stroke volume was calculated as the quo-
tient of the cardiac output and heart rate. Total peripheral
resistance was calculated as the quotient of the mean sys-
temic pressure and cardiac output. Ejection fraction index
was determined as the quotient of the maximal stroke
volume recorded during the volume load and the corre-
sponding left ventricular volume determined from the iso-
lated left ventricular pressure-volume relation at the maxi-
mal end-diastolic pressure during volume loading.
Statistical analysis. All results are presented as mean
values ± standard error of the mean. Statistical comparisons
Table I. Prethoracotomy Hemodynamics and Body Weight in Untreated and Captopril-Treated
Rats After 21 Days
p Values
No MI MI MI Capt MI x Capt
Heart rate (beats/min)
Capt 324 ± 9 301 ± X
0.021 0.829 0.840
Water 324 ± 7 297 ± 10
AoP (mm Hg)
Capt 98 ± I 88 ± 4
0.004 O.UOI 0.425
Water 118 ± 4 101 ± 4
LV SP (mm Hg)
Capt 108 ± 2 103 ± 5
0.141 0.005 0.464
Water 131 ± 3 113 ± 4
LV dP/dt (mm Hgls)
Capt 7.900 ± 532 6.028 ± 193
<0.001 0.095 0.124
Water 8.985 ± 115 6.075 ± 361
RAP (mm Hgl
Capt 0.0 ± 0.0 0.1 ± 0.1 0.192 ll.170 0.286
Water U.I ± 0.1 1.3 ± 0.7
Body weight Ig)
Capt 297 ± II 291 ± 7 0.136 0.057 0.442
Water 324 ± 7 302 ± 10
No.
Capt 4 9
Water 7 8
Values are mean values ± SEM. Treated rats received captopril (Capt) starting 2 h after surgery. AOP = mean
aortic pressure: dP/dt = rate of rise of left ventricular pressure: LV = left ventricular: MI = myocardial infarction:
MI x Capt = interaction between myocardial infarction and captopril treatment: No. = number of rals: RAP = right
atrial pressure: SP = systolic pressure: Water = untreated rats.
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peripheral resistance index was decreased by captopril.
Volume loading revealed differences between the control
rats and rats with infarction in the response to preload stress.
Cardiac and stroke volume indexes during the volume load
were decreased by myocardial infarction. Captopril-treated
rats tended to have increased peak cardiac and stroke
volume indexes compared with control rats; however, the
differences did not reach statistical significance. The ejection
fraction index was decreased by myocardial infarction and
increased by captopril treatment.
Left ventricular pressure-volume relation. The pressure-
volume relation (Fig. 2) was shifted rightward by myocardial
infarction (p < O.OOj). This shift indicates increased left
ventricular volumes in the rats with infarction. Captopril
resulted in a shift of the pressure-volume relation to the left
(p < 0.00 I) and there was a pronounced effect of captopril in
the rats with infarction (p = 0.029). Compared with the
untreated rats with infarction. in treated rats with infarction
the pressure-volume relation was shifted leftward. indicating
less ventricular dilation. In addition, the left ventricular
volume at rest end-diastolic pressure was increased by
myocardial infarction (p < 0.001) and decreased by captopril
treatment (p = 0.007). There was an interaction of captopril
and infarction (p = 0.014) as evidenced by a significant
Figure I. Left ventricular end-diastolic pressure (LYEDP) (A). left
ventricular weight/body weight ratio (LY WT/BW) (8) and right
ventricular weight/body weight ratio (RY WT/BW) (C) in captopril-
treated (filled bars) and untreated (HP) (open bars) rats with (Mil
and without (NO Ml) myocardial infarction 21 days after surgery. p
:s 0.00 I in A, Band C. respectively. for rats without versus rats with
infarction: p = 0.006. p < 0.001 and p = 0.002 in A, Band C.
respectively. for captopril-treated versus untreated rats: and p =
0.006. p = 0.031 and p = 0.006 in A, Band C, respectively. for an
interaction of myocardial infarction and captopril treatment.
were made using two-way analysis of variance. The left
ventricular pressure-volume data were analyzed using two-
way analysis of covariance, with the left ventricular pressure
being the covariate. For both the two-way analysis of
variance and covariance, three statistical hypothesis were
tested: I) that there was no difference between diseased and
normal rats; 2) that there was no difference between treated
and untreated groups; and 3) that there was interaction
between disease and treatment. If the last hypothesis was
rejected and a significant interaction was found, unpaired t
tests were used to test for intergroup differences with the
Bonferroni modification with two preplanned comparisons.
Statistical comparisons between delayed and immediate
treatment with captopril in the long-term studies were made
using Student's t test.
Results
Effects of captopril treatment for 48 h. The mean aortic
pressures for sham-operated rats recorded at 48 h after
operation were significantly decreased by captopril treat-
ment. Untreated sham-operated rats (n = 4) had a mean
aortic pressure of 105 ± 2 mm Hg and treated rats (n = 5)
had a mean aortic pressure of 82 ± 6 mm Hg (p < 0.01).
Effects at 21 days of captopril started 2 h after infarction.
Among 40 rats that survived for 2 h, 5 in the control and 7 in
the treatment group died before study. Most of these deaths
(10 of 12) occurred within 48 h. Therefore. 28 rats were
studied and. of these, 17 had a large myocardial infarction.
Prethoracotomy hemodynamic values and body weights
(Table 1). Mean aortic pressure was decreased in the rats
with infarction and in rats without infarction treated with
captopril. Left ventricular systolic pressure was not signifi-
cantly decreased in the rats with infarction, but was de-
creased by treatment with captopril. Myocardial infarction
produced a large decrease in the maximal rate of rise of left
ventricular pressure (dP/dt). Right atrial pressures and body
weights were unchanged by infarction or treatment. Myo-
cardial infarct size was similar in both groups (36 ± 1% in the
treated group versus 35 ± 1% in the untreated group).
Captopril produced a large decrease in left I'entricular
end-diastolic pressure (Fig. I). There was an interaction of
captopril treatment and infarction indicating a greater effect
of treatment in the rats with infarction than in those without
infarction. Captopril also decreased both right and left
ventricular weights relative to body weight (Fig. I). In the
case of right ventricular weight/body weight ratio, an inter-
action of captopril and infarction was present as evidenced
by a significant effect of captopril in rats with infarction.
Hemodynamic values after thoracotomy (Table 2). Rest
cardiac, stroke volume and total peripheral resistance in-
dexes were not significantly altered by myocardial infarc-
tion. Rest cardiac and stroke volume indexes were not
significantly altered by captopril treatment. but the total
lACC Vol. 16. No.4
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Table 2. Post-Thoracotomy Hemodynamics in Untreated and Captopril-Treated Rats
After 21 Days
p Values
No Ml MI MI Capt MI x Capt
Rest
CI (ml/min per kg)
Capt 265 :t 13 236 :t 8
0.228 0.804 0.266Water 254 :t 10 253 :t 15
TPRI (mm Hg/ml per min per kg)
Capt 0.31 :t 0.2 0.33 :t 0.0 I
0.608 0.017 0.856
Water 0.43 :t OJ 0.36 :t 0.02
SVI (ml/beat per kg)
Capt 0.70 :t 0.05 0.61 :t 0.03
0.395 0.835 0.244
Water 0.66 :t 0.02 0.67 :t 0.06
Stress (volume loading)
Peak CI (ml/min per kgl
Capt 424 ± 17 357 :t 9
0.001 0.245 0.927
Water 403 ± 20 335 :t 18
Peak SVI (ml/beat per kg)
Capt 1.19 ± 0.06 1.06 ± 0.ll3
0.006 0.237 0.548
Water 1.17 ± 0.06 0.96 ± 0.06
Peak EDVI (ml/kg)
Capt 1.32 ± 0.09 2.64 ± 0.13
<0.001 0.005 0.519
Water 1.72 ± 0.12 3.24:t0.13
Ejection fraction index (0/,')
Capt 91 :t 3 41 ± 2
<0.001 <0.001 0.062
Water 70 ± 3 30 ± 2
Values are mean values ± SEM. Treated rats received captopril starting 2 h after surgery. CI = cardiac index:
EDVI =end-diastolic volume index: ESVI = end-systolic volume index: SVI = stroke volume index: TPRI = total
peripheral resistance index: other abbreviations as in Table I.
difference between the hemodynamic values of treated and
untreated rats with infarction. The left ventricular volume at
maximal end-diastolic .pressure recorded during volume
loading was increased by myocardial infarction and reduced
by captopril treatment (Table 2).
Comparison of immediate and delayed captopril treatment
(Tables 3 and 4). Before thoracotomy, heart rate, mean
arterial pressure, left ventricular systolic and end-diastolic
pressures, left ventricular dP/dt. right atrial pressure and
heart and body weights were not significantly different
between the two treatment groups (immediate versus de-
layed) (Table 3). After thoracotomy, heart rate, mean arte-
rial pressure, left ventricular systolic and end-diastolic pres-
sures, right atrial pressure. cardiac index. total peripheral
resistance index and stroke volume index were not signifi-
cantly different between the two groups (Table 4). The
end-diastolic volume at rest end-diastolic pressure was 2.35
± 0.05 mllkg in the immediate treatment group and 2.39 ±
0.12 mllkg in the delayed treatment group. The ejection
fraction index was 35 ± 3% in the immediate treatment
group and 34 ± 2% in the delayed treatment group. Myocar-
dial infarct size was 35 ± 3% in the immediate treatment
group and 36 ± 1% in the delayed treatment group.
Effects of captopril treatment for 4 months. Of the 23 rats
assigned at 2 h after infarction to the group to receive
captopril immediately. 17 were alive at 4 months. There
were two rats with a small infarct that were excluded from
the analysis, nine rats with a large infarct and six rats with no
infarction. At 21 days, 15 rats were assigned to the delayed
treatment group and 29 to the control group. In the delayed
treatment group at the time of hemodynamic study, nine rats
had a large infarct. one rat had a small infarct and was
excluded from further analysis and two rats had no infarc-
tion. Among the 29 control rats, 24 survived to 4 months to
undergo study; of these, 14 had a large infarct, 3 had a small
infarct and 7 had no infarction.
Prethoracotomy hemodynamics in captopril-treated versus
untreated rats after 4 months (Table 5). Because no signifi-
cant difference was found in the rats in the immediate or
delayed treatment groups, these groups were combined to
form the captopril-treated group. Heart rate and mean aortic
and left ventricular systolic pressures were decreased by
myocardial infarction and captopril. Left ventricular systolic
pressure was not significantly decreased by infarction, but
was decreased by captopril. Myocardial infarction produced
a large decrease in left ventricular dP/dt. Right atrial pres-
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Figure 2. Left ventricular pressure-volume relation for rats without (A)
and with (Bl infarction 2\ days after attempted coronary artery ligation.
In each graph. the volume at end-diastolic pressure is noted by the X.
In the rats with infarction. the operating end-diastolic volume was 2.99
± 0.20 ml/kg in untreated (H20) and 1.95 ± 0.15 ml/kg in captopril
(CAPr)-treated rats. Myocardial infarction resulted in a rightward shift
of the pressure-volume relation. indicating increased left ventricular
volume that was reduced by captopril treatment.
sure was increased by myocardial infarction. but was not
significantly altered by captopril. Body weight was de-
creased 6% by captopril in rats without and 7% in rats with
infarction. The size of the infarct was similar in both groups:
35 ± I% in the captopril treatment group and 36 ± I% in the
untreated group.
Captopril resulted in a 42% reduction in left ventricular
end-diastolic pressure (Fig. 3). Also. treatment decreased
right and left ventricular weight in the groups with and
without infarction. In the case of right ventricular weight!
body weight ratio. an interaction of captopril and infarction
was present. which was due to a significant effect of capto-
pril in rats with infarction.
Post-thoracotomy hemodynamics in captopril-treated ver·
sus untreated rats after 4 months (Table 6). Rest cardiac.
stroke volume and total peripheral resistance indexes were
not significantly altered by myocardial infarction. Rest car-
diac and stroke volume indexes were not significantly altered
by captopril. but total peripheral resistance index was de-
creased. Cardiac and stroke volume indexes recorded during
the volume load were decreased by myocardial infarction.
There was a trend for captopril treatment to increase both
Table 3. Hemodynamics and Body and Heart Weight at
4 Months in Rats With a Large Myocardial Infarct Treated With
Captopril Started Immediately or Delayed for 2\ Days After
Coronary Ligation
Immediate Capt Delayed Capt
(n = 9) (n = 9)
Heart rate (beats/min) 317 ± 3 311 ± 4
AoP (mm Hg) 83 ± 4 81 ± 4
LV SP (mm Hg) 103 ± 5 93 ± 4
LV EOP (mm Hg) 17 ± 3 16 ± 4
LV dP/dt (mm Hgls) 5.266 ± 324 5.011 ± 253
RAP Imm Hg) 1.8 ± 0.8 0.7 ± 0.4
Body weight (g) 398 ± 16 413 ± 7
LV weight/body 1.73 ± 0.02 1.74 ± 0.03
weight (mglg)
RV weight/body 0.53 ± 0.05 0.70 ± 0.06
weight (mglg)
Total heart weight/ 2.26 ± 0.06 2.43 ± 0.07
body weight (mglg)
Values are mean values ± SEM. Abbreviations as in Tables 1 and 2.
peak cardiac and stroke volume indexes; however. values
did not reach statistical significance. The ejection fraction
index was decreased by myocardial infarction and increased
by captopril treatment. There was an interaction of captopril
treatment and infarction.
Left ventricular pressure-volume relation. The pressure-
volume relation (Fig. 4) was shifted rightward by myocardial
infarction (p < 0.001). Captopril resulted in a shift of the
pressure-volume relation to the left compared with values in
untreated rats (p = 0.001). There was an interaction of
Table 4. Open Chest Rest and Stress Hemodynamics at
4 Months in Rats With a Large Myocardial Infarct Treated With
Captopril Started Immediately or Delayed for 2\ Days After
Coronary Ligation
Immediate Capt Delayed Capt
In = 9) (n = 9)
Rest
Heart rate Ibeats/min) 326 ± 10 343 ± 4
AoP (mm Hg) 78 ± 3 80 ± 2
LV SP (mm Hg) 91 ± 2 97 ± 3
LV EOP (mm Hg) 16 ± 2 14 ± 2
RAP (mm Hg) 1.8 ± 0.8 1.9 ± 0.4
Cardiac index (ml/kg) 177 ± 6 176 ± 9
TPRI (mm Hg/ml per 0.44 ± 0.02 0.47 ± 0.03
min per kg)
SVI (ml/beat per kg) 0.55 ± 0.03 0.51 ± 0.03
Stress Ivolume loading)
CI (ml/kg) 280 ± 14 288 ± 11
SVI (ml/beat per kg) 0.96 ± 0.05 0.94 ± 0.03
LV EOP (mm Hg) 30 ± 3 33 ± 2
RAP Imm Hg) 9.9 ± 1.3 8.0 ± 1.0
Values are mean values ± SEM. Abbreviations as in Tables 1 and 2.
lACC Vol. 16, No.4
October 1990:967-77
GAY
CAPTOPRIL AFTER MYOCARDIAL INFARCTION
973
Table 5. Prethoracotomy Hemodynamics and Body Weight in Untreated (Water) and Captopril
(Capt)-Treated Rats After 4 Months
p Values
No MI MI MI Capt MI x Capt
Heart rate (beats/min)
Capt 327 ± 8 313 ± 3
0.003 <0.001 0.526
Water 307 ± 8 291 ± 8
AoP (mm Hg)
Capt 96 ± 4 85 ± 3
0.001 <0.001 0.337
Water 121 ± 4 104 ± 3
LV SP (mm Hg)
Capt 105 ± 3 98 ± 3
0.001 <0.001 0.040
Water 142 ± 5 121 ± 6
LV dP/dt (mm Hg/s)
Capt 7.375 ± 203 5.138 ± 208
<0.001 0.008 0.076
Water 8.171 ± 475 5.828 ± 366
RAP (mm Hgl
Capt 0.3 ± 0.2 1.3 :+: 0.5
0.009 0.177 0.256
Water 0.4 ± 0.2 2.4 :+: 0.6
Body weight (g)
Capt 411 :+: 15 405 :+: 10
0.874 0.040 0.767
Water 437 :+: 6 435 :+: 23
No.
Capt 8 18
Water 7 14
Values are mean values:+: SEM. Abbreviations as in Table I.
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Figure 3. Left ventricular end-diastolic pressure (LVEDP) (A), left
ventricular weight/body weight ratio (LV WT/BW) (8) and right
ventricular weight/body weight ratio (RV WT/BW) (Cj in captopril-
treated (filled bars) and untreated (H~O) (open bars) rats with
(Ml) and without (NO Ml) myocardial infarction 4 months after
surgery. p < 0.001. p = 0.285 and p < 0.001 in A, Band C.
respectively, for rats without versus rats with infarction; p = 0.008,
p < 0.001 and p < 0.001 in A, Band C. respectively, for captopril-
treated rats versus untreated rats; and p = 0.076, p = 0.840 and p =
0.001 in A, Band C, respectively, for an interaction of captopril
treatment and myocardial infarction.
captopril and infarction (p = 0.049). The left ventricular
volume at rest end-diastolic pressure was increased by
myocardial infarction (p < 0.001) and decreased by captopril
treatment (p < 0.001). There was an interaction of captopril
and infarction (p = 0.006), which was due to a difference in
the treated and untreated rats with myocardial infarction.
The volume at peak end-diastolic pressure during the volume
load was increased by myocardial infarction and decreased
by captopril treatment (Table 6).
Comparison of changes after 21 days and after 4 months of
treatment. The magnitude of the changes noted after 4
months of captopril treatment started immediately after
infarction was very similar to that observed after only 21
days of treatment. For the 4 month values, these changes
were calculated using only the results in rats started on
treatment immediately. Left ventricular weight/body weight
ratio was decreased 16% and 11% and right ventricular
weight/body weight ratio was decreased 49% and 37% after
4 months and 21 days of treatment, respectively. Left
ventricular end-diastolic pressure was decreased 39% and
55% after 4 months and 2I days of treatment, respectively.
Ejection fraction index increased 43% after 21 days of
treatment and 33% after 4 months. End-diastolic volumes at
rest and during the volume load were decreased 35% and
19%, respectively, after 21 days of treatment and 28% and
24%, respectively. after 4 months of treatment.
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Table 6. Post-Thoracotomy Hemodynamics in Untreated (Water) and Captopril (Capt)-Treated
Rats After 4 Months
p Values
No MI Ml Ml Capt MI x Capt
Rest
CI (ml/min per kg)
Capt 199 :!: 4 176:!: 6 0.115
Water 184 :!: 7 174:!: 14
0.476 0.283
TPRI (mm Hglml per min per kg)
Capt 0.41 :!: 0.2 0.46 :!: 0.02 0.092 0.003
Water 0.53 :!: 0.2 0.61 :!: 0.06
0.631
SVI (ml/beat per kg)
Capt 0.58 :!: 0.03 0.53 :!: 0.02 0.729 0.778 0.201
Water 0.55 :!: 0.03 0.54 :!: 0.04
Stress (volume loading)
Peak CI (ml/min per kg)
Capt 346:!: 14 284 :!: 9 <0.001 0.471 0.089
Water 359:!: 17 252:!: II
Peak SVI (ml/beat per kg)
Capt 1.13 :!: 0.04 0.95 :!: 0.03 <0.001 0.886 0.190
Water 1.19 :!: 0.06 0.90 :!: 0.04
Peak EDVI (ml/kg)
Capt 1.69 ± 0.07 2.75 :!: 0.12 <0.001 0.005 0.008
Water 1.70 ± 0.08 3.41 ±0.15
Ejection fraction index (%)
Capt 68 ± 4 35 :!: I <0.001 0.224
Water 70 :!: 3 27 :!: I
0.041
Values are mean values:!: SEM. Abbreviations as in Tables I and 2.
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Discussion
Beneficial effects of captopril treatment. The results of the
current study show that treatment with captopril started
immediately after myocardial infarction decreased left ven-
tricular filling pressure and ventricular dilation and improved
ejection fraction index compared with findings in untreated
rats with infarction studied after 21 days or 4 months. The
changes observed after 21 days of treatment were of the
same magnitude as those seen after treatment for 4 months.
Treatment started immediately offers no apparent advantage
over treatment started 21 days after infarction when evalu-
ated after long-term administration (4 months) of captopril.
These findings suggest that the mechanism for the immediate
beneficial effects may be the same as for long-term adminis-
tration initiated after the infarction is healed.
Survival after myocardial infarction has been shown to be
related to ventricular function and volumes 01,12). Treat-
ment that limits progressive ventricular enlargement pre-
serves ventricular function (3) and improves long-term
survival in experimental myocardial infarction 08l. Two
clinical studies 09,20) have demonstrated that after myocar-
dial infarction, captopril treatment produced a reduction in
ventricular dilation that was associated with improvement of
global ventricular function and exercise tolerance. Although
it has not been previously studied, the benefits of treatment
with captopril could be enhanced in theory by initiation of
therapy immediately after myocardial infarction. The poten-
tial benefits of initiation of treatment soon after infarction
include a reduction in infarct expansion and earlier effects on
the noninfarcted myocardium.
The noninfarcted myocardium: role of hypertrophy and
dilation. Hypertrophy of the surviving myocardium devel-
ops within 3 days of myocardial infarction in the rat. The
extent of hypertrophy is related to infarct size (5,6) and after
a large infarct, this compensatory hypertrophy fails to re-
place the infarcted myocardium (5,6,21). If the remaining
myocardium has depressed function because of deranged
myocardial cellular function. further compromise of left
ventricular systolic function would be expected. Recently. in
patients studied at 6 and 40 weeks after myocardial infarc-
tion, hypertrophy of the noninfarcted region was observed
with use of serial two-dimensional echocardiography (15).
Patients who demonstrated hypertrophy of the noninfarcted
segment were much more likely to show improved rest and
exercise ejection fractions than were patients who failed to
develop hypertrophy. The development of hypertrophy may
be a critical factor in determining functional outcome after
infarction. The second mechanism that the ventricle
JACC Vol. 16, No.4
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Figure 4. Left ventricular pressure-volume relation for rats with (B)
and without (A) infarction 4 months after attempted coronary artery
ligation, In each graph, the volume at end-diastolic pressure is noted
by the X, In the rats with infarction (B), the operating end-diastolic
volume was 3.24 ± 0,16 ml/kg in untreated (H~O) and 2.37 ± 0,07
ml/kg in captopril (CAPT)-treated rats. Myocardial infarction re-
sulted in a rightward shift of the pressure-volume relation, indicating
increased left ventricular volume that was reduced by captopril
treatment
uses to respond to loss of functioning myocardial tissue is
ventricular dilation, which allows for ejection of the same
stroke volume with decreased shortening, Therefore, hyper-
trophy and ventricular dilation are important compensatory
mechanisms on which the ventricle must rely to maintain
stroke volume and cardiac output. Whether blocking these
critical compensatory responses after myocardial infarction
is beneficial or harmful is a question of considerable interest.
Early effects of captopril treatment. The results of the
current study clearly demonstrate that captopril started
immediately after myocardial infarction and continued for 21
days produced a reduction in left and right ventricular mass
and in left ventricular dilation without adversely affecting
ventricular performance, This is shown by the rest cardiac
and stroke volume indexes, which were maintained at nor-
mal levels. In addition, the ventricle had the capacity to
respond to stress as demonstrated by the cardiac and stroke
indexes during volume loading, which were not diminished
in captopril-treated rats compared with values in untreated
rats with infarction. In fact, there was a tendency for these
values to be improved and the ejection fraction index ob-
tained during volume loading was significantly increased by
captopril treatment after only 21 days. Therefore, despite a
potential for deleterious effects, a benefit of early treatment
was demonstrated.
Late effects of captopril treatment. The extent of changes
observed after 4 months of captopril treatment was very
similar to that observed after 21 days of treatment. Again,
there was a reduction in left and right ventricular mass and in
left ventricular dilation without an adverse effect on ventric-
ular performance. The hemodynamic values at rest and
response to volume loading were essentially identical to
those observed only 21 days after infarction. It is unclear
why the extent of improvement with long-term treatment
was no greater than that noted after only 21 days of treat-
ment. One could speculate that there is a limit to the benefits
that can be derived from alteration of loading conditions and
that this limit is probably related to the degree of initial
myocardial dysfunction, which is related to the extent of
infarction, It may also be reasonable to speculate that the
improvement noted after 21 days of treatment is not due to a
reduction in infarct expansion. If captopril influenced infarct
expansion, it would be expected that the changes would be
additive, with the long-term effect on remodeling of the
noninfarcted region to produce a greater effect after 4
months of treatment than that observed after 21 days,
Potential mechanisms. By 21 days after coronary ligation
in the rat, infarct scar is well formed and mature (22).
Treatment initiated at this time would not be expected to
reduce infarct expansion. Treatment for 4 months initiated
21 days after the infarction when the infarct region would be
well healed produced changes that were identical to those
observed with treatment initiated immediately after myocar-
dial infarction. This finding suggests that the primary effect
of captopril treatment in the current study was not due to an
effect on infarct expansion in either treatment group,
Infarct expansion has been shown to be present at I to 2
days after infarction, although the degree of expansion is
mild (grade I to 2+ on a scale of I to 4+). By 7 days after
infarction, grade 3to 4+ expansion is found in >60% of large
infarcts (2,3). A significant decrease in mean aortic pressure
at 48 h after a sham operation was produced by captopril;
therefore, an effect on infarct expansion might have been
expected. However, earlier effective therapy may be neces-
sary to reduce infarct expansion. In the current study, early
parenteral therapy was not given to avoid the possibility of
confounding effects on infarct size rather than infarct expan-
sion or the remodeling process, Ultimately, optimal treat-
ment of acute myocardial infarction will likely evolve to
attempt to preserve ventricular function at every possible
stage from the time of coronary occlusion to recovery years
later and will probably involve therapy to limit infarct size,
reduce infarct expansion and limit long-term progressive
remodeling,
Previous studies. Our results are consistent with the
earlier study of Pfeffer et aL (13), who reported that admin-
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istration of captopril for 3 months in rats with myocardial
infarction resulted in attenuation of ventricular remodeling
compared with findings in untreated rats. The extent of the
changes observed in our study are very similar to those
reported previously (13). In the study by Pfeffer et al. (13).
therapy was started either 2 or 21 days after infarction and.
although data were not presented. it was reported that there
were no differences between the two groups when they were
studied 3 months later. Therefore, the current results would
corroborate those of the previous study and extend them in
that it appears that even earlier initiation of treatment with
captopril does not offer an advantage over treatment initi-
ated 21 days after infarction in this model (13).
Regulation of ventricular remodeling after myocardial
infarction remains poorly understood. Loading conditions
appear to have an important role as evidenced by data
showing that a reduction in preload and afterload with
captopril attenuates the remodeling process (13,14). In con-
trast, afterload reduction alone with hydralazine does not
limit the remodeling after a large myocardial infarct (14); this
finding indicates that preload reduction or the combination
of preload and afterload reduction is necessary to reduce
progressive left ventricular enlargement after myocardial
infarction. Other factors that may alter the remodeling
process, including adrenergic stimulation. circulating hor-
mones and neuroendocrinologic factors, have not been well
studied.
Limitations. Although the rat model is useful for studies
of left ventricular dilation and performance after myocardial
infarction, certain limitations of the model and this study
deserve discussion. Unlike patients with coronary artery
disease, these animals have normal coronary anatomy in the
area other than the distribution of the ligated vessel. The
effects of coronary artery disease on the viable myocardium
after myocardial infarction could be substantial and could
alter the response to therapy such as captopril. The primary
purpose of the current study was to evaluate the effects of
captopril on cardiac performance and size. Although early
treatment produced no obvious large effect on survival,
these data must be interpreted with caution. No measures
were taken to ensure equal distribution of rats with infarc-
tion in the groups. The presence of or size of an infarct was
not studied in the rats that died; therefore, the cause of the
deaths is not known. Most of the rats would be expected to
have had myocardial infarction because the mortality rate
after a sham operation is small. Thoracic infection or trauma
related to the procedure could not be excluded as a cause of
death in some cases. Therefore, the current study does not
provide useful information regarding the effects of early
treatment on survival.
The small effect of captopril on body weight was unex-
pected. The explanation for this effect is unclear; however, it
is unlikely that a 6% to 7% decrease in body weight has
physiologic significance. Previous studies (13,23.24) have
reported similar findings. It is possible that the reduction in
end-diastolic pressure allowed the rats to be more active
and, therefore. they had a tendency toward reduced body
mass. A contributing factor might be a reduction in total
body sodium and water content as a result of improved
cardiac performance.
Conclusions. Our results again demonstrate the benefit of
long-term vasodilator treatment with captopril on progres-
sive ventricular remodeling after myocardial infarction.
Early treatment with captopril after infarction reduced ven-
tricular dilation and preserved ventricular function. There-
fore, it may be safe to use these agents early after infarction
and continuation of this treatment over long periods may
produce effects that could be expected to be beneficial.
However, after 4 months of treatment, there was no differ-
ence in the benefit seen with early treatment compared with
treatment initiated at 21 days. This finding could be inter-
preted to indicate that it may be reasonable to withhold
captopril treatment early after myocardial infarction until
hemodynamic and clinical stability have been demonstrated.
Additional studies are necessary to understand the factors
that regulate and control ventricular size and performance
after myocardial infarction.
I thank Nancy Walker. Keith Perkins. Melissa Carucci and Andrew Walker
for their technical assistance and Steve Goldman. MD for review of the
manuscript.
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